Рет қаралды 70
Experts from Bioptimus, Qubit Pharmaceuticals, and InstaDeep will discuss how they’re tackling real-world challenges like scaling AI models and building specialized bioAI models to accelerate clinical insights.
Discover how quantum computing optimizes drug research, how custom AI models in biology rely on precise data handling, and the techniques behind generative bioAI models for protein and DNA analysis.
Julia Gimbernat Mayol, Head of Product for DeepChain™ at @instadeepAI
Jean-Philippe Vert, CEO at Bioptimus
Robert Marino, CEO. at Qubit Pharmaceuticals
Moderator: Chris O'Brien, Founder & Editor of @TheFrenchTechJournal